Published in PLoS One on December 09, 2011
Towards the elements of successful insect RNAi. J Insect Physiol (2013) 1.42
siPools: highly complex but accurately defined siRNA pools eliminate off-target effects. Nucleic Acids Res (2014) 1.01
Designing Ago2-specific siRNA/shRNA to Avoid Competition with Endogenous miRNAs. Mol Ther Nucleic Acids (2014) 0.97
miRNA-like duplexes as RNAi triggers with improved specificity. Front Genet (2012) 0.82
Improved knockdown from artificial microRNAs in an enhanced miR-155 backbone: a designer's guide to potent multi-target RNAi. Nucleic Acids Res (2015) 0.81
Multiplexing seven miRNA-Based shRNAs to suppress HIV replication. Mol Ther (2014) 0.79
A screen for F1 hybrid male rescue reveals no major-effect hybrid lethality loci in the Drosophila melanogaster autosomal genome. G3 (Bethesda) (2014) 0.79
Guidelines for the optimal design of miRNA-based shRNAs. Methods (2016) 0.78
Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS. Adv Drug Deliv Rev (2016) 0.78
5' Unlocked Nucleic Acid Modification Improves siRNA Targeting. Mol Ther Nucleic Acids (2013) 0.78
Mg2+ effect on argonaute and RNA duplex by molecular dynamics and bioinformatics implications. PLoS One (2014) 0.75
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49
A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science (2001) 31.33
Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell (2001) 25.86
Asymmetry in the assembly of the RNAi enzyme complex. Cell (2003) 22.18
Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev (2001) 21.82
MicroRNA maturation: stepwise processing and subcellular localization. EMBO J (2002) 19.47
Functional siRNAs and miRNAs exhibit strand bias. Cell (2003) 19.15
The Microprocessor complex mediates the genesis of microRNAs. Nature (2004) 17.70
Processing of primary microRNAs by the Microprocessor complex. Nature (2004) 14.59
Rational siRNA design for RNA interference. Nat Biotechnol (2004) 14.16
Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell (2006) 11.98
Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell (2002) 10.30
Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell (2005) 9.35
Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes Dev (2004) 9.32
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell (2005) 9.27
Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods (2002) 6.67
The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol (2004) 6.56
Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell (2005) 6.47
Structural basis for double-stranded RNA processing by Dicer. Science (2006) 5.86
Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol (2005) 5.60
Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res (2004) 5.46
Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by dicer-1. Cell (2007) 5.26
siRNA function in RNAi: a chemical modification analysis. RNA (2003) 4.93
Sorting of Drosophila small silencing RNAs. Cell (2007) 4.67
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A (2008) 4.53
Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res (2003) 3.85
Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev (2009) 3.62
The Argonaute protein family. Genome Biol (2008) 2.83
Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes Dev (2009) 2.73
An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics (2006) 2.46
In vivo activity of nuclease-resistant siRNAs. RNA (2004) 2.33
Improving the efficiency of RNA interference in mammals. Nat Rev Genet (2004) 2.13
On the art of identifying effective and specific siRNAs. Nat Methods (2006) 2.09
ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol (2009) 2.04
Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol (2009) 2.01
DEQOR: a web-based tool for the design and quality control of siRNAs. Nucleic Acids Res (2004) 1.97
Asymmetric RNA duplexes mediate RNA interference in mammalian cells. Nat Biotechnol (2008) 1.97
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J Clin Invest (2010) 1.91
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res (2009) 1.84
Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. Nat Struct Mol Biol (2009) 1.81
Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics (2006) 1.69
Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res (2007) 1.68
Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA. PLoS One (2009) 1.63
Strand-specific 5'-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity. RNA (2007) 1.61
Sequence characteristics of functional siRNAs. RNA (2005) 1.59
A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med (2006) 1.55
Improved silencing properties using small internally segmented interfering RNAs. Nucleic Acids Res (2007) 1.53
A protocol for designing siRNAs with high functionality and specificity. Nat Protoc (2007) 1.49
Defining the optimal parameters for hairpin-based knockdown constructs. RNA (2007) 1.48
Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency. Nat Biotechnol (2005) 1.47
Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming. Bioinformatics (2004) 1.41
Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes. Proc Natl Acad Sci U S A (2011) 1.28
A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects. Nucleic Acids Res (2010) 1.26
Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection. Nucleic Acids Res (2008) 1.21
Modulation of thermal stability can enhance the potency of siRNA. Nucleic Acids Res (2010) 1.14
Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology (2007) 1.09
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo. Mol Biosyst (2010) 1.07
Multilayer checkpoints for microRNA authenticity during RISC assembly. EMBO Rep (2011) 1.06
Optimization of duplex stability and terminal asymmetry for shRNA design. PLoS One (2010) 1.05
Both strands of siRNA have potential to guide posttranscriptional gene silencing in mammalian cells. PLoS One (2009) 0.91
Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element. Biochem Biophys Res Commun (2005) 0.89
Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. PLoS One (2011) 0.89
Focusing on RISC assembly in mammalian cells. Biochem Biophys Res Commun (2008) 0.83
RNA polymerase III can drive polycistronic expression of functional interfering RNAs designed to resemble microRNAs. Nucleic Acids Res (2009) 0.82
2'-O-methyl-modified anti-MDR1 fork-siRNA duplexes exhibiting high nuclease resistance and prolonged silencing activity. Oligonucleotides (2010) 0.78
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature (2003) 7.56
RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med (2003) 7.37
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol (2005) 6.40
siRNA-directed inhibition of HIV-1 infection. Nat Med (2002) 6.36
miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One (2007) 5.43
Transvascular delivery of small interfering RNA to the central nervous system. Nature (2007) 5.21
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell (2008) 4.32
Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med (2001) 4.17
Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet (1991) 2.77
Identification of Mycobacterium tuberculosis by polymerase chain reaction. Lancet (1990) 2.39
Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J Virol (2003) 2.26
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood (2001) 2.13
CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol (2005) 2.02
Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood (2002) 1.94
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood (2001) 1.74
Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev (2009) 1.65
Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA. PLoS One (2009) 1.63
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol Ther (2009) 1.55
A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med (2006) 1.55
Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood (2005) 1.54
Dynamic regulation of T cell immunity by CD43. J Immunol (2002) 1.45
Migration and differentiation of CD8+ T cells. Immunol Rev (2002) 1.41
TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J Immunol (1998) 1.37
Negative regulation of T cell homing by CD43. Immunity (1998) 1.36
Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther (2010) 1.28
The prospect of silencing disease using RNA interference. JAMA (2005) 1.24
Cutting Edge: Distinct NK receptor profiles are imprinted on CD8 T cells in the mucosa and periphery during the same antigen challenge: role of tissue-specific factors. J Immunol (2007) 1.12
Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Trends Mol Med (2003) 1.10
The functional CD8 T cell response to HIV becomes type-specific in progressive disease. J Clin Invest (2002) 1.09
Maternal neural responses to infant cries and faces: relationships with substance use. Front Psychiatry (2011) 1.08
Newer gene editing technologies toward HIV gene therapy. Viruses (2013) 1.07
Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol (2009) 1.06
Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation. J Allergy Clin Immunol (2007) 1.05
A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43. J Exp Med (2000) 1.05
Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol Med (2009) 1.04
Interfering antiviral immunity: application, subversion, hope? Trends Immunol (2006) 1.03
P-body components LSM1, GW182, DDX3, DDX6 and XRN1 are recruited to WNV replication sites and positively regulate viral replication. Virology (2012) 1.02
NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site. PLoS Pathog (2006) 0.99
Concurrent generation of effector and central memory CD8 T cells during vaccinia virus infection. PLoS One (2008) 0.98
Association of indoor air pollution with acute lower respiratory tract infections in children under 5 years of age. Paediatr Int Child Health (2012) 0.94
Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc Natl Acad Sci U S A (2012) 0.94
Isolation of Enterovirus 70 during conjunctivitis epidemic in Delhi in 1981. Indian J Med Res (1982) 0.93
Avoiding the kiss of death: how HIV and other chronic viruses survive. Curr Opin Immunol (2002) 0.93
The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells. J Immunol (2003) 0.92
Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol (2009) 0.91
Rubella infection: the Indian scene. Rev Infect Dis (1985) 0.91
Regulation of in vitro and in vivo T cell activation by CD43. Int Immunol (1998) 0.90
Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. PLoS One (2011) 0.89
Ago-2-mediated slicer activity is essential for anti-flaviviral efficacy of RNAi. PLoS One (2011) 0.88
The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes. Immunology (2003) 0.88
Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. Mol Ther (2010) 0.87
RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA? Expert Opin Biol Ther (2010) 0.87
CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis. J Immunol (1995) 0.86
Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease. AIDS Behav (2015) 0.85
Antibody-mediated delivery of siRNAs for anti-HIV therapy. Methods Mol Biol (2011) 0.85
Humanized mice for studying human leukocyte integrins in vivo. Methods Mol Biol (2012) 0.85
Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2. PLoS One (2012) 0.84
Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice. Virol J (2011) 0.82
Correlates of acute lower respiratory tract infections in children under 5 years of age in India. Int J Tuberc Lung Dis (2013) 0.82
Effective suppression of HIV-1 by artificial bispecific miRNA targeting conserved sequences with tolerance for wobble base-pairing. Biochem Biophys Res Commun (2008) 0.81
The effect of allogenetic bone marrow-derived mesenchymal stem cell transplantation on lung aquaporin-1 and -5 in a rat model of severe acute pancreatitis. Hepatogastroenterology (2012) 0.80
Translational regulation by the 3' untranslated region of the dengue type 2 virus genome. Am J Trop Med Hyg (2009) 0.80
Granulocyte colony-stimulating factor-primed bone marrow: an excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia. Chin Med J (Engl) (2015) 0.80
Cross-clade CD8 T-cell responses to HIV(IIIB) and Chinese B' and C/B' viruses in North American and Chinese HIV-seropositive donors. J Acquir Immune Defic Syndr (2004) 0.80
Silencing TNF-α in macrophages and dendritic cells for arthritis treatment. Scand J Rheumatol (2013) 0.80
Effects of dissolved oxygen on survival and immune responses of scallop (Chlamys farreri Jones et Preston). Fish Shellfish Immunol (2006) 0.80
[Cryosurgery Combined with Radioactive Seeds and Release-controlled Chemical Drugs Implantation for the Treatment of Lung Carcinoma.]. Zhongguo Fei Ai Za Zhi (2009) 0.79
Anaesthetic management of closed mitral valvotomy for severe mitral stenosis with traumatic kyphoscoliosis. Indian J Anaesth (2010) 0.79
Interaction of dietary Bacillus subtilis and fructooligosaccharide on the growth performance, non-specific immunity of sea cucumber, Apostichopus japonicus. Fish Shellfish Immunol (2010) 0.78
Effects of dietary β-glucan, mannan oligosaccharide and their combinations on growth performance, immunity and resistance against Vibrio splendidus of sea cucumber, Apostichopus japonicus. Fish Shellfish Immunol (2011) 0.78
[TACE with Ar-He cryosurgery combined minimal invasive technique for the treatment of primary NSCLC in 139 cases]. Zhongguo Fei Ai Za Zhi (2010) 0.78
Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy. Virology (2011) 0.78
A Toll receptor from Chinese shrimp Fenneropenaeus chinensis is responsive to Vibrio anguillarum infection. Fish Shellfish Immunol (2008) 0.77
Mobile physician reporting of clinically significant events-a novel way to improve handoff communication and supervision of resident on call activities. J Patient Saf (2014) 0.77
A cytotoxic substance produced by a wild culture of Lactobacillus casei D-34 against tumour cells. Indian J Exp Biol (1989) 0.77
Mutation analyses of integrated HBV genome in hepatitis B patients. J Genet Genomics (2008) 0.77